Muscle loss may hold key to IBD treatment success
NCT ID NCT07482163
Summary
This study aims to understand how muscle loss (sarcopenia) affects treatment outcomes for people with inflammatory bowel disease (IBD). Researchers will use routine CT scans to measure muscle mass in 50 adult patients who are receiving biologic therapies. The goal is to determine if muscle loss influences how well these treatments work for IBD patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CT-ASSESSED SARCOPENIA OUTCOMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.